SCHEMBL6975815

SCHEMBL6975815

CCCCCOC(=O)COc1cc2c(=O)c(Cc3cccnc3)cn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
CHRNA7 P36544 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
NFKB1 P19838 2/20 0.34
NFKB2 Q00653 2/20 0.34
RELA Q04206 2/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 1/20 0.34
EGFR P00533 10/20 0.33
FPR1 P21462 1/20 0.33
FPR2 P25090 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983106 0.95 TSHR (0.35) LMNACHRNA7MAPTTSHRFPR1
SCHEMBL6983182 0.92 TSHR (0.41) LMNAMAPTPOLBSMN1; SMN2TSHR
SCHEMBL6983183 0.91 CNR1 (0.37) LMNACNR1CNR2MAPTSMN1; SMN2
SCHEMBL6975197 0.88 ALDH1A1 (0.36) CNR1CNR2MAPTFPR1FPR2
SCHEMBL6981489 0.87 FPR1 (0.36) MAPTFPR1FPR2KDM4EALDH1A1
SCHEMBL6983568 0.87 GABRA1 (0.37) MAPTFPR1FPR2ALDH1A1
SCHEMBL6980559 0.86 FPR1 (0.35) MAPTSMN1; SMN2FPR1FPR2KDM4E
SCHEMBL6982874 0.86 MCL1 (0.36) MAPTSMN1; SMN2FPR1FPR2KDM4E
SCHEMBL6978829 0.86 GABRA1 (0.36) CHRNA7MAPTFPR1FPR2ALDH1A1
SCHEMBL6983481 0.85 GABRA1 (0.38) LMNACNR1CNR2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed